Annual report pursuant to Section 13 and 15(d)

Income Taxes (Details)

v3.20.1
Income Taxes (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Sep. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Income Tax Disclosure [Abstract]        
United States loss before income taxes [1]     $ (17,310,582) $ (7,665,284)
China loss before income taxes     (759,579) (387,012)
Total loss before income taxes $ (5,376,268) $ (14,140,010) $ (18,070,161) $ (8,052,296)
[1] For the years ended December 31, 2019 and 2018, amount of $0 and $572,613, respectively, is included in the United States loss before income taxes, which is not included in the Company's consolidated income tax return, because the Company owns only 60% of Genexosome. The U.S. tax law requires 80% ownership to consolidate.